about
Novel therapeutic targets in myeloma bone disease.Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Therapeutic Management of a Substantial Pelvic Aneurysmatic Bone Cyst Including the Off-Label Use of Denosumab in a 35-Year-Old Female Patient.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Denosumab: A comprehensive review.
@en
Denosumab: A comprehensive review.
@nl
type
label
Denosumab: A comprehensive review.
@en
Denosumab: A comprehensive review.
@nl
prefLabel
Denosumab: A comprehensive review.
@en
Denosumab: A comprehensive review.
@nl
P2860
P356
P1476
Denosumab: A comprehensive review.
@en
P2093
Prasad Narayanan
P2860
P304
P356
10.4103/2278-330X.119895
P577
2013-10-01T00:00:00Z